Skip to Content

Resources for Canadian Healthcare Professionals and Patients

SPIKEVAX™ (elasomeran mRNA vaccine) is indicated for active immunization against coronavirus disease 2019 (COVID‑19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) virus in individuals 12 years of age and older.

The current SPIKEVAX vial and carton labels have the product name 'COVID-19 Vaccine Moderna' and are not Canadian-specific as global, English-only labels are being used for the Canadian market.

For more information, please see the Health Product Risk Communications below.

Please find helpful resources for SPIKEVAX below. Check back as we update with additional educational content as it becomes available.

Drug Identification Number (DIN): 02510014

Helping Patients
Understand
What to Expect

UPDATED

Storage, Handling, Dosage
and Administration

2nd Dose
Reminder Card

SPIKEVAX Product
Monograph

November 12, 2021

Moderna Vaccine Story

Frequently Asked Questions

Videos

Withdrawing a SPIKEVAX 0.5mL (100 mcg mRNA) Primary Series Dose Video

NEW

Withdrawing a 0.5mL (100 mcg mRNA) Primary Series Dose

This video is intended to be used to show proper dosing of a 0.5mL (100 mcg mRNA) primary series dose for SPIKEVAX™ (elasomeran mRNA vaccine).

This video is intended to be used to show proper dosing and administration techniques for SPIKEVAX and is intended for healthcare professionals only.

Content portrayed in this video is only for instructional purposes. Actual handling and product manipulation should be performed in accordance with the Product Monograph and Health Canada-approved label, local regulations, and standard operating procedures.

Please contact 1-866-MODERNA (1-866-663-3762) with any inquiries pertaining to the content of this video.

For illustrative purposes only. Actual SPIKEVAX not shown. Please see full Product Monograph for more details.

0.5 mL (100 mcg mRNA) primary series dose

Moderna

Withdrawing a SPIKEVAX 0.25mL (50 mcg mRNA) Booster Dose Video

NEW

Withdrawing a 0.25mL (50 mcg mRNA) Booster Dose

This video is intended to be used to show proper dosing of a 0.25mL (50 mcg mRNA) booster dose for SPIKEVAX™ (elasomeran mRNA vaccine).

This video is intended to be used to show proper dosing and administration techniques for SPIKEVAX and is intended for healthcare professionals only.

Content portrayed in this video is only for instructional purposes. Actual handling and product manipulation should be performed in accordance with the Product Monograph and Health Canada-approved label, local regulations, and standard operating procedures.

Please contact 1-866-MODERNA (1-866-663-3762) with any inquiries pertaining to the content of this video.

For illustrative purposes only. Actual SPIKEVAX not shown. Please see full Product Monograph for more details.

0.25 mL (50 mcg mRNA) booster dose

Moderna

SPIKEVAX Primary Series vs Booster Dose Video

NEW

SPIKEVAX™ (elasomeran mRNA vaccine) Primary Series vs Booster Dose

This video is intended to be used to show proper dosing of a 0.5mL (100 mcg mRNA) primary series dose compared to a 0.25mL (50 mcg mRNA) booster dose of SPIKEVAX™ (elasomeran mRNA vaccine).

This video is intended to be used to show proper dosing and administration techniques for SPIKEVAX and is intended for healthcare professionals only.

Content portrayed in this video is only for instructional purposes. Actual handling and product manipulation should be performed in accordance with the Product Monograph and Health Canada-approved label, local regulations, and standard operating procedures.

Please contact 1-866-MODERNA (1-866-663-3762) with any inquiries pertaining to the content of this video.

For illustrative purposes only. Actual SPIKEVAX not shown. Please see full Product Monograph for more details.

Primary Series dose - 0.5 mL (100 mcg mRNA)

Booster dose – 0.25 mL (50 mcg mRNA)

Moderna

Proper Vial Swirl Technique for SPIKEVAX Video

NEW

Proper Vial Swirl Technique for SPIKEVAX™ (elasomeran mRNA vaccine)

This video is intended to be used to show a proper vial swirl technique for SPIKEVAX™ (elasomeran mRNA vaccine).

This video is intended to be used to show proper dosing and administration techniques for SPIKEVAX and is intended for healthcare professionals only.

Content portrayed in this video is only for instructional purposes. Actual handling and product manipulation should be performed in accordance with the Product Monograph and Health Canada-approved label, local regulations, and standard operating procedures.

Please contact 1-866-MODERNA (1-866-663-3762) with any inquiries pertaining to the content of this video.

For illustrative purposes only. Actual SPIKEVAX not shown. Please see full Product Monograph for more details.

Swirl vial gently after thawing and between each withdrawal.

Do not shake. Do not dilute the vaccine.

Please see full Product Monograph for more details.

Moderna

How to Puncture the SPIKEVAX Multidose Vial up to 20 Times Video

NEW

How to puncture the SPIKEVAX™ multidose vial up to 20 times

This video is intended to be used to show a proper way to puncture the SPIKEVAX™ multidose vial multiple times.

This video is intended to be used to show proper dosing and administration techniques for SPIKEVAX and is intended for healthcare professionals only.

Content portrayed in this video is only for instructional purposes. Actual handling and product manipulation should be performed in accordance with the Product Monograph and Health Canada-approved label, local regulations, and standard operating procedures.

Please contact 1-866-MODERNA (1-866-663-3762) with any inquiries pertaining to the content of this video.

For illustrative purposes only. Actual SPIKEVAX not shown. Please see full Product Monograph for more details.

Use a different insertion point at various locations of the vial septum for each withdrawal to reduce potential leakage of vaccine.

Do not puncture the vial more than 20 times.

Moderna

Lipid Nanoparticles Explainer Video

Moderna Lipid Nanoparticles Explainer Video

The most powerful defense against disease has always lived within each of us: Our immune system.

And now, after a decade of research, Moderna is introducing mRNA-based technology that can unleash the immune system’s ability to help fight disease like never before.

Here’s how. The human body uses mRNA–code-carrying molecules made naturally in our cells – to provide the instructions for life. By harnessing mRNA, we can teach cells to make the proteins we need to help fight disease.

The trick is getting the instructions into the cells. Because, as incredible as these messengers are, they’re also incredibly delicate.

The breakthrough we needed was the development of Lipid Nanoparticles, or “LNPs” for short. LNPs are tiny, fatty droplets that carry mRNA safely, like a shipping container.

They’re called “nano” for a reason. They’re just 100 nanometers across–one one hundred-thousandth of a centimeter–and surround mRNA, forming a protective shell for the journey to our cells.

As soon as the LNPs accomplish their mission, they dutifully dissolve and disappear–helping our immune system defend us.

Our mRNA technology has the potential to change the way we help prevent and treat viral diseases, cancer, and rare diseases in ways previously unimaginable.

moderna

CA-MRNA-2100001 06/2021

Reporting Adverse Events

Managing marketed health product-related side effects depends on healthcare professionals and patients reporting them. Any serious or unexpected side effects in patients receiving SPIKEVAX should be reported to your local Health Unit.

If a patient experiences a side effect following immunization, please complete the Adverse Events Following Immunization (AEFI) Form appropriate for your province/territory and send it to your local Health Unit.

In addition, you can report side effects to Moderna at 1-866-MODERNA (1-866-663-3762).

Product Concerns

All designated vaccination sites need to maintain security around the storage of SPIKEVAX within their facilities.

Make sure that vials of SPIKEVAX arrive and are stored in their original packaging. If you suspect that the SPIKEVAX you have purchased may be counterfeit, if there are any irregularities with packaging, and/or with the arrival of the shipments, please contact us at 1‑866‑663‑3762 or visit www.modernatx.com, or report a complaint to Health Canada.